Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 2
1974 2
1975 2
1976 1
1977 2
1978 5
1979 5
1980 7
1981 10
1982 9
1983 7
1984 9
1985 20
1986 13
1987 12
1988 10
1989 6
1990 7
1991 8
1992 9
1993 17
1994 15
1995 9
1996 9
1997 5
1998 2
1999 4
2000 2
2001 4
2002 3
2003 6
2004 6
2005 9
2006 11
2007 14
2008 12
2009 4
2010 3
2011 6
2012 9
2013 1
2014 5
2015 5
2016 3
2017 6
2018 9
2019 5
2020 4
2021 4
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

330 results

Results by year

Filters applied: . Clear all
Page 1
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial.
Sands BE, Irving PM, Hoops T, Izanec JL, Gao LL, Gasink C, Greenspan A, Allez M, Danese S, Hanauer SB, Jairath V, Kuehbacher T, Lewis JD, Loftus EV Jr, Mihaly E, Panaccione R, Scherl E, Shchukina OB, Sandborn WJ; SEAVUE Study Group. Sands BE, et al. Among authors: greenspan a. Lancet. 2022 Jun 11;399(10342):2200-2211. doi: 10.1016/S0140-6736(22)00688-2. Lancet. 2022. PMID: 35691323 Clinical Trial.
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A; ExteNET Study Group. Martin M, et al. Lancet Oncol. 2017 Dec;18(12):1688-1700. doi: 10.1016/S1470-2045(17)30717-9. Epub 2017 Nov 13. Lancet Oncol. 2017. PMID: 29146401 Clinical Trial.
Multicentric reticulohistiocytosis: a critical review.
Selmi C, Greenspan A, Huntley A, Gershwin ME. Selmi C, et al. Among authors: greenspan a. Curr Rheumatol Rep. 2015 Jun;17(6):511. doi: 10.1007/s11926-015-0511-6. Curr Rheumatol Rep. 2015. PMID: 25900189 Review.
Antihistamines and itch.
Thurmond RL, Kazerouni K, Chaplan SR, Greenspan AJ. Thurmond RL, et al. Among authors: greenspan aj. Handb Exp Pharmacol. 2015;226:257-90. doi: 10.1007/978-3-662-44605-8_15. Handb Exp Pharmacol. 2015. PMID: 25861785 Review.
Signal Detection and Methodological Limitations in a Real-World Registry: Learnings from the Evaluation of Long-Term Safety Analyses in PSOLAR.
Bissonnette R, Gottlieb AB, Langley RG, Leonardi CL, Papp KA, Pariser DM, Uy J, Lafferty KP, Langholff W, Fakharzadeh S, Berlin JA, Brouwer ES, Greenspan AJ, Strober BE. Bissonnette R, et al. Among authors: greenspan aj. Drug Saf. 2021 Jun;44(6):699-709. doi: 10.1007/s40264-021-01065-z. Epub 2021 Jun 2. Drug Saf. 2021. PMID: 34075572 Free PMC article. Review.
Erosive osteoarthritis.
Greenspan A. Greenspan A. Semin Musculoskelet Radiol. 2003 Jun;7(2):155-9. doi: 10.1055/s-2003-41349. Semin Musculoskelet Radiol. 2003. PMID: 12920653 Review.
Avascular necrosis.
Mirzai R, Chang C, Greenspan A, Gershwin ME. Mirzai R, et al. Among authors: greenspan a. Compr Ther. 1998 May;24(5):251-5. Compr Ther. 1998. PMID: 9626482 Review.
330 results